Circulation 2011-05-10

Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo.

Richard C Jin, Christopher E Mahoney, Laura Coleman Anderson, Filomena Ottaviano, Kevin Croce, Jane A Leopold, Ying-Yi Zhang, Shiow-Shih Tang, Diane E Handy, Joseph Loscalzo

Index: Circulation 123 , 1963-73, (2011)

Full Text: HTML

Abstract

Glutathione peroxidase-3 (GPx-3) is a selenocysteine-containing plasma protein that scavenges reactive oxygen species in the extracellular compartment. A deficiency of this enzyme has been associated with platelet-dependent thrombosis, and a promoter haplotype with reduced function has been associated with stroke risk.We recently developed a genetic mouse model to assess platelet function and thrombosis in the setting of GPx-3 deficiency. The GPx-3((-/-)) mice showed an attenuated bleeding time and an enhanced aggregation response to the agonist ADP compared with wild-type mice. GPx-3((-/-)) mice displayed increased plasma levels of soluble P-selectin and decreased plasma cyclic cGMP compared with wild-type mice. ADP infusion-induced platelet aggregation in the pulmonary vasculature produced a more robust platelet activation response in the GPx-3((-/-)) than wild-type mice; histological sections from the pulmonary vasculature of GPx-3((-/-)) compared with wild-type mice showed increased platelet-rich thrombi and a higher percentage of occluded vessels. Cremaster muscle preparations revealed endothelial dysfunction in the GPx-3((-/-)) compared with wild-type mice. With a no-flow ischemia-reperfusion stroke model, GPx-3((-/-)) mice had significantly larger cerebral infarctions compared with wild-type mice and platelet-dependent strokes. To assess the neuroprotective role of antioxidants in this model, we found that manganese(III) meso-tetrakis(4-benzoic acid)porphyrin treatment reduced stroke size in GPx-3((-/-)) mice compared with vehicle-treated controls.These findings demonstrate that GPx-3 deficiency results in a prothrombotic state and vascular dysfunction that promotes platelet-dependent arterial thrombosis. These data illustrate the importance of this plasma antioxidant enzyme in regulating platelet activity, endothelial function, platelet-dependent thrombosis, and vascular thrombotic propensity.


Related Compounds

Related Articles:

Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency.

2014-12-01

[Thromb. Haemost. 112(6) , 1182-9, (2014)]

Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease.

2015-01-01

[Autophagy 11(2) , 385-402, (2015)]

Determination of total creatine kinase activity in blood serum using an amperometric biosensor based on glucose oxidase and hexokinase.

2015-11-01

[Talanta 144 , 604-11, (2015)]

Mechanism of ATP turnover inhibition in the EJC.

2009-01-01

[RNA 15 , 67-75, (2009)]

Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist.

2011-02-01

[Arterioscler. Thromb. Vasc. Biol. 31 , 416-422, (2011)]

More Articles...